Medicine and Dentistry
Bleeding
16%
Bone Necrosis
16%
Calcitonin Gene Related Peptide
10%
Charlson Comorbidity Index
16%
Comorbidity
20%
COVID-19
100%
Cylindroma
16%
Disease Free Survival
11%
Disease Specific Survival
12%
Diseases
17%
Division
16%
Esophagus
16%
Fistula
11%
Head and Neck Cancer
16%
Hearing Impairment
13%
Hypercalcaemia
16%
Idiopathic Intracranial Hypertension
16%
Intubation
53%
Laryngeal Cancer
38%
Laryngectomy
14%
Larynx Squamous Cell Carcinoma
16%
Long Term Survival
11%
Neck
19%
Neoadjuvant Chemotherapy
14%
Neoplasm
14%
Odds Ratio
16%
Oropharynx Squamous Cell Carcinoma
39%
Osteosarcoma
16%
Otorhinolaryngology
53%
Outpatient
16%
Overall Survival
55%
Parathyroid
16%
Parathyroid Hormone
16%
Parotidectomy
16%
Prognostic Factor
20%
Program Director
12%
Radiation Therapy
28%
Recurrent Disease
12%
Sensorineural Hearing Loss
16%
Simulation Training
16%
Squamous Cell Carcinoma
16%
Surgery
20%
Surgical Approach
16%
Survival Analysis
16%
Survival Rate
20%
Tinnitus
16%
Trachea
11%
Tracheal Agenesis
16%
Tracheomalacia
16%
Wart Virus
33%
Keyphrases
Adjuvant Chemotherapy
8%
Advanced Laryngeal Cancer
16%
Age-adjusted Charlson Comorbidity Index
10%
Chronic Esophageal Foreign Body
16%
Dynamic Risk Model
16%
George Washington University
5%
Head-and-neck
16%
High-frequency Range
5%
Intraoperative Parathyroid Hormone Monitoring
16%
Life-cycle Model
16%
Loss Threshold
5%
Mandibular Osteoradionecrosis
16%
Neoadjuvant Chemotherapy
12%
Oropharyngeal Hemorrhage
16%
Osteosarcoma
16%
Otolaryngology Residency
16%
Overall Survival
8%
Perceived Impact
16%
Prolonged Intubation
5%
Provider Comfort
16%
Rapid Cycle
16%
Sinonasal Adenoid Cystic Carcinoma
16%
Spat
10%
Survival Outcomes
16%
T3 Laryngeal Cancer
8%
Total Laryngectomy
8%
Tracheomalacia
16%
Treatment Survival
16%
Treatment Trends
16%
United States
16%
Vertical Division
16%
